Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
History shows that the top-performing stocks often have an RS Rating of at least 80 in the early stages of their moves. See if Agilent Technologies stock can continue to show renewed price strength and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Is Agilent Technologies Stock A Buy?
Agilent Technologies stock is within a buy range after climbing above a 141.24 entry in a cup with handle. The proper buying range extends to 5% above the initial entry. Once a stock moves above that range, it's best to hold off investing and wait for it to set up another buying opportunity..
Although earnings and sales growth came in at -6% and -6%, respectively, in the latest report, that marked acceleration for both EPS and revenue.
Agilent Technologies stock earns the No. 7 rank among its peers in the Medical-Research Equipment/Services industry group. Medpace Holdings, Icon PLC and Natera are among the top 5 highly rated stocks within the group.
